123 AZACITIDINE (AZA) COMBINED WITH IDARUBICIN (IDA) IN HIGHER RISK MDS (HRMDS) – RESULTS OF A PHASE I/II STUDY BY THE GFM

Autor: Sebert, M., Ades, L., Stamatoullas, A., Braun, T., Delaunay, J., de Renzis, B., Jeddi, R., Meddeb, B., Berger, M. Hunault, Samey, B., Chermat, F., Chaffaut, C., Chevert, S., Fenaux, P.
Zdroj: In Leukemia Research April 2015 39 Supplement 1:S63-S63
Databáze: ScienceDirect